MBody AI Ltd. (MBAI) Stock Score, Valuation & Financial Research

MBody AI Ltd. is in the Healthcare sector and Biotechnology industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for MBAI

MBody AI Ltd. does not currently have a complete Wall Street Score. The stored market price is USD 3.24. These figures are a research snapshot, not a buy or sell recommendation.

What MBody AI Ltd. does

MBody AI Ltd. designs and develops embodied artificial intelligence software for autonomous workforce and operational automation. The company's platform provides Perception AI for computer vision and environmental understanding, Cognitive AI for adaptive decision-making, and Learning AI for continuous on-site machine learning. Its platform also provides dynamic task and route optimization, along with fleet intelligence and coordination across multi-unit operations. The company serves the hospitality, office, warehouse, and healthcare sectors, supporting applications such as facility maintenance, workspace cleaning, autonomous logistics, inventory management, and sanitation. MBody AI Ltd. was founded in 2004 and is based in Mississauga, Canada.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

MBody AI generates revenue through its hardware-agnostic MBody AI Orchestrator platform, which integrates and coordinates diverse robotic and sensor-based systems for enterprise clients. The company provides this AI infrastructure to enable autonomous workforce operations, charging for platform deployment and ongoing orchestration services across sectors including hospitality, healthcare, logistics, and data centers.

Products and services

  • MBody AI Orchestrator, a hardware-agnostic enterprise-scale AI platform that integrates and coordinates robotic and intelligent devices from various manufacturers.

Brands and product families

  • MBody AI Orchestrator — The company's primary proprietary AI platform for robotic and sensor-based system integration. Source

Customer types

Fortune 500 enterprises; Blue-chip brands.

Business relationships and partnerships

  • Check-Cap Ltd. — A strategic merger agreement completed on August 26, 2026, where MBody AI became a wholly-owned subsidiary of Check-Cap Ltd. Source
  • ARC Group International Inc. — Provider of an equity line of credit facility to support the company's financial operations. Source

Business strengths to evaluate

  • Hardware-agnostic AI platform architecture Source
  • Proven enterprise-scale deployments Source

Business risks and research considerations

  • Operational risks associated with scaling commercial deployments Source
  • Dependence on successful integration of merger activities Source

Sources: Company research source · MBody AI Orchestrator · Check-Cap Ltd. · ARC Group International Inc.

Company research refreshed 2026-10-13. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

MBAI financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 3.24
Market capitalization:
3.25M (currency not supplied)
Revenue:
USD 0.00
Net income:
USD 4.14M
Free cash flow:
USD -46K
Cash:
USD 2K
Total debt:
USD 16K
EPS:
USD 4.62
P/E ratio:
0.7x

What stands out

  • Free cash flow is USD -46K, negative for the stored period.
  • The balance sheet shows USD 2K of cash versus USD 16K of total debt, with debt exceeding cash on these two reported measures.
  • The current research record carries a missing revenue history warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Debt exceeds cash by USD 14K using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for MBAI

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • How long can MBAI fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • Is MBAI's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • What does the current missing revenue history warning mean for the reliability or interpretation of MBAI's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-05.

Research-input completeness: 73% of the scoring inputs required for this public page are currently available.

How to research MBAI

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.